Zhonghua Zhu

Associate Director, Process Development @TScan Therapeutics

Cambridge, MA, US
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Feb 2025 — Present

Associate Director, Process Development @TScan Therapeutics

View department →

Waltham, MA, US

Leadership & Organizational Development • Built and led a high-performing team of 5 reports, including Ph.D-level scientists and functional managers. Provided mentorship and strategic career planning within and beyond direct team; contributed to broader talent development initiatives. Process Development – Autologous TCR-T Cell Therapy • Directed end-to-end process optimization for multiple TCR-T programs targeting hematologic and solid tumors. Designed and optimized core unit operations. Led DoE-based process characterization and comparability studies to support IND filings and clinical manufacturing readiness • Supported GMP manufacturing, supported MSAT for internal and external tech transfer, supported AD’s assay developmentVector Development – Non-Viral Gene Delivery • Developed and optimized a non-viral transposon/transposase vector system for clinical-stage TCR-T cell therapy, including mRNA transposase and DNA payload constructs. Drove vector design decisions to balance expression, stability, manufacturability, and regulatory requirements. Led CDMO selection, technology transfer, and GMP manufacturing for both mRNA and plasmid vectors Regulatory & Compliance • Authored and reviewed CMC sections for multiple IND and IND amendments. Participated in FDA meetings as CMC representative, addressing regulatory questions and presenting development strategies Strategic Projects, Business Development & IP • Technical lead in cross-functional evaluation of next-generation therapy opportunities, including lentivirus based in vivo CAR-T, iPSC-derived and allogeneic T-cell platforms. Conducted competitive and scientific landscape assessments on gene delivery vectors (viral, non-viral, LNP, VLP), gene editing tools, in vivo/ex vivo T-cell engineering technologies, and CDMO manufacturability • Performed scientific diligence; authored scopes of work (SOWs), MTAs, and technical briefs to support strategic collaborations • Contributed to multiple IP filings

EDUCATION

2011 — 2017

New York University

Doctor of Philosophy - PhD, Neurobiology

N/A

Nanjing Normal University

Bachelor of Science - BS, Biotechnology

N/A

Nanjing Normal University

Master of Science - MS, Developmental biology

ABOUT ZHONGHUA ZHU

PhD in Neurobiology from NYU. Biotech professional with 8 years industry experienceSenior scientist from Biogen: Experience in early drug discovery of neurological diseases: SME in disease modeling, molecular biology, stem cell (iPSC), CRISPR genome editing. Manage a team with 4 reports. Experience in CRO managementAssociate Director from TScan Therapeutics: Experience in Process Development of TCR-T autologous cell therapy for oncology, SME in viral / non-viral vectors and delivery, cell engineering and production at scales. Manage a team with 5 reports. Experience in CRO / CDMO management, regulatory IND filing and business development

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Zhonghua Zhu — Associate Director, Process Development at TScan Therapeutics in Cambridge, MA, US | Unifers